Anti-NIBA2/ FAM129B/ C9orf88 monoclonal antibody

Anti-NIBA2/ FAM129B/ C9orf88 antibody for FACS & in-vivo assay

Target products collectionGo to FAM129B/FAM129B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2119-Ab-1/ GM-Tg-hg-MP2119-Ab-2Anti-Human FAM129B monoclonal antibodyHuman
GM-Tg-rg-MP2119-Ab-1/ GM-Tg-rg-MP2119-Ab-2Anti-Rat FAM129B monoclonal antibodyRat
GM-Tg-mg-MP2119-Ab-1/ GM-Tg-mg-MP2119-Ab-2Anti-Mouse FAM129B monoclonal antibodyMouse
GM-Tg-cynog-MP2119-Ab-1/ GM-Tg-cynog-MP2119-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM129B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2119-Ab-1/ GM-Tg-felg-MP2119-Ab-2Anti-Feline FAM129B monoclonal antibodyFeline
GM-Tg-cang-MP2119-Ab-1/ GM-Tg-cang-MP2119-Ab-2Anti-Canine FAM129B monoclonal antibodyCanine
GM-Tg-bovg-MP2119-Ab-1/ GM-Tg-bovg-MP2119-Ab-2Anti-Bovine FAM129B monoclonal antibodyBovine
GM-Tg-equg-MP2119-Ab-1/ GM-Tg-equg-MP2119-Ab-2Anti-Equine FAM129B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2119-Ab-1/ GM-Tg-hg-MP2119-Ab-2; GM-Tg-rg-MP2119-Ab-1/ GM-Tg-rg-MP2119-Ab-2;
GM-Tg-mg-MP2119-Ab-1/ GM-Tg-mg-MP2119-Ab-2; GM-Tg-cynog-MP2119-Ab-1/ GM-Tg-cynog-MP2119-Ab-2;
GM-Tg-felg-MP2119-Ab-1/ GM-Tg-felg-MP2119-Ab-2; GM-Tg-cang-MP2119-Ab-1/ GM-Tg-cang-MP2119-Ab-2;
GM-Tg-bovg-MP2119-Ab-1/ GM-Tg-bovg-MP2119-Ab-2; GM-Tg-equg-MP2119-Ab-1/ GM-Tg-equg-MP2119-Ab-2
Products NameAnti-FAM129B monoclonal antibody
Formatmab
Target NameFAM129B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FAM129B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species NIBA2/ FAM129B/ C9orf88 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm005174mouse Fam129b Lentivirus plasmid
    ORF Viral VectorvGMLPm005174mouse Fam129b Lentivirus particle


    Target information

    Target IDGM-MP2119
    Target NameFAM129B
    Gene ID64855,227737,362115,707403,609251,101096769,613747,100070508
    Gene Symbol and Synonyms9130404D14Rik,bA356B19.6,C9orf88,FAM129B,MEG-3,MINERVA,NIBAN2,OC58,RGD1307018
    Uniprot AccessionQ96TA1,B4F7E8
    Uniprot Entry NameNIBA2_HUMAN,NIBA2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136830
    Target ClassificationN/A

    The target: FAM129B, gene name: FAM129B, also named as C9orf88, MEG-3, MINERVA, OC58, bA356B19.6. Enables transcription coactivator activity. Involved in several processes, including gonadotropin secretion; positive regulation of transcription regulatory region DNA binding activity; and regulation of cellular macromolecule biosynthetic process. Located in several cellular components, including adherens junction; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.